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Child Cancer Experience Modulates the Relationship Between Child and Parent
Hypothalamic-Pituitary Adrenal (HPA) Axis Functioning
By
Sarah Dinces
BA., Psychology, 2010
M.S., Psychology, 2013
Abstract
Objective: We examine how parental stress and pediatric cancer might jointly predict
child HPA function using a non-invasive method of cortisol assessment (hair samples).
Methods: Parents and children from healthy control and pediatric cancer survivor
families participated. Multilevel modeling was applied to data from a nested-design study
(85 children, 5-18 years old, from 64 families, healthy controls: n=32; cancer survivors:
n=32) to determine the relationship between parent salivary and child hair cortisol
measures.
Results: No main effect of the cancer experience on child cortisol was found. Parental
cortisol positively correlated with child cortisol levels within healthy controls, while there
was no association within pediatric cancer survivor families. For cancer survivor
children given corticosteroids, there was a negative association between parent and child
cortisol levels. Among cancer survivor children not given corticosteroids, the relationship
between parent and child was the same as for healthy control families.
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Conclusion: Only when children are exposed to corticosteroids, the relationship between
parent and child HPA function is significantly changed by the cancer experience. This
study provides no evidence that the cancer illness alone alters child HPA function.
However, direct perturbation of the child’s HPA axis by corticosteroid exposure may
have lasting effects on children’s stress physiology.
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INTRODUCTION
The preponderance (66%) of pediatric cancer survivors experience at least one
“late effect”, an outcome related to the disease process or treatment that occurs more than
six months after the completion of treatment. These late effects may manifest as either
physical or psychological impairments and are, in a substantial minority of cases, severe
or life threatening (Institute of Medicine, 2003; Oeffinger et al., 2006). Psychological late
effects include both neurocognitive (Moore, 2005) and psychosocial effects (Patenaude &
Kupst, 2005). Psychological late effects are highly variable, with common manifestations
including but not limited to behavior problems, depression, anxiety, and post-traumatic
stress symptoms, as well as deficits in attention, executive functioning, memory, and
general intelligence (Moore, 2005; Moore, Ater, & Copeland, 1992; Mulhern,
Wasserman, Fairclough, & Ochs, 1988; Schultz et al., 2007; Stam, Grootenhuis, & Last,
2001).
The pediatric cancer experience encompasses a series of ongoing interrelated
stressors, such as painful and long-term treatment, frequent and unpredictable hospital
stays, the threat of mortality, and late effects associated with treatment (Kazak & Noll,
2015). Treatment severity, in particular, has received ample attention as this component
of the cancer experience has influences on child outcomes (Anderson, Smibert, Ekert, &
Godber, 1994; Brinkman et al., 2012; Moleski, 2000; Moore, 2005; Peterson et al., 2008;
Reddick et al., 2006). This research has found that as the severity of treatment increases,
children are more likely to suffer from late effects (Moleski, 2000). However, while
treatment severity related to radiation, chemotherapy and neurosurgery has direct effects
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on pediatric cancer survivor outcomes, it is currently unknown the extent to which these
effects may also be caused via increased stress or dysregulation of the HPA axis.
Chronic stress associated with pediatric cancer may influence several different
child developmental outcomes, including global symptoms of stress and distress as well
as child HPA axis functioning. HPA function is an essential outcome measure for child
development not only because it can be impacted by the amount of stress to which an
individual is exposed (Del Giudice, Ellis, & Shirtcliff, 2011), but also because
dysfunction of the HPA axis is associated with many common psychological health
problems such as depression (Spijker & van Rossum, 2012) and anxiety (Faravelli et al.,
2012; Ising et al., 2012). Previous research suggests children who suffer from chronic
diseases such as wasting disorders and HIV (Zeitler, Travers, & Kappy, 1999) as well as
children who have been maltreated (Fisher, Van Ryzin, & Gunnar, 2011) have altered
HPA function. Survivors of pediatric cancer generally have higher levels of global
distress than children who experienced few health problems (Lesko, 1990; Zeltzer et al.,
2008) as well as higher rates of PTSD than healthy controls and children who have a
history of abuse (Pelcovitz et al., 1998).
As these findings reveal differences in pediatric cancer survivors’ anxiety and
PTSD symptomology compared to healthy controls, it is logical to consider that these
psychological processes may be related to changes in HPA axis function. Research
investigating whether pediatric cancer may affect child HPA axis function has found that
survivors of pediatric Acute Lymphoblastic Leukemia (ALL) demonstrate altered HPA
function (Gordijn et al., 2012). Yet, it is virtually impossible to untangle the effects of
corticosteroid treatment from those of the cancer experience during treatment. Treatment
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studies examining corticosteroid exposure both within the cancer and non-cancer
literatures show similar increased levels of anxiety and an increased risk for behavioral
and psychiatric problems (Drozdowicz & Bostwick, 2014; Pound et al., 2012), as well as
increased treatment related anxiety (Pound et al., 2012). The cancer experience is no
doubt a prolonged stressor, which can alter HPA regulation; alternatively, or additionally,
some cancer treatments, particularly corticosteroids, have the potential to directly
influence the development of the HPA axis, particularly during childhood. A focus on
child cancer survivors provides an opportunity to inform the study of stress regulation as
survivors are no longer being treated with medications that disrupt HPA function.
Contextual factors may impact how children respond to the experience of a
chronic illness such as cancer. When examining the contextual effect of parent stress and
distress, it is found that non all pediatric cancer survivors are equally negatively affected
by the cancer experience, and that parental stress may mitigate the negative effects of
cancer. Previous research examining the effect of parental distress on child day-to-day
functioning after cancer found that for ALL survivors, high parent distress was associated
with high child functional impairment (Hile, Erickson, Agee, & Annett, 2014). Thus,
children’s ability to function in everyday life after having cancer is related to stress in
their family environment. In contrast to the above findings, at least one study reports that
depression symptomology in children with cancer is less well predicted by parental
distress than in healthy control children (Robinson, Gerhardt, Vannatta, & Noll, 2007).
Yet, both of these studies are limited to parent proxy reports, of child functioning, which
may bias the results. This methodological problem highlights the need for research to
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examine both parent and child stress using alternative measures that can assess
physiological markers of stress.
Literature exists that supports the impact of early life stress interaction with
parental cortisol levels to shape child HPA functioning. This research (Clearfield, CarterRodriguez, Merali, & Shober, 2014; Hibel, Granger, Blair, Finegood, & Investigators,
2014) highlights that as child stress exposure increases, the concordance between parental
factors and child cortisol levels decrease. Mothers and children in low socioeconomic
status (SES) families demonstrate less concordance between their cortisol levels than
high SES families (Clearfield et al., 2014). This may be attributed to the increased stress
of being in a low socioeconomic environment, but additionally, these mothers may not
spend as much time with their infants and therefore may not have as many shared
experiences with the infant, leading to a decreased relationship with the child.
Experimental manipulation of cortisol synchronicity by Hibel and colleagues (2014),
found that the concordance between parent and child cortisol decreases as the child is
exposed to stress. Given that cancer is both a major adversity and one that removes
children from the home environment for significant periods of time, it can be
hypothesized that children with cancer might not only have elevated cortisol but may also
exhibit weaker correlations with their parents than healthy controls.
The aim of the present study was to investigate how the early experience of the
chronic stress of cancer, in addition to parental stress, might predict child HPA function
as expressed in cortisol production. In order to study this relationship we examined parent
and child cortisol is both healthy control and pediatric cancer survivor populations.
Specifically, we test the following hypotheses: (1) early experience of cancer will affect
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child cortisol levels; and (2) early experience of cancer modifies the association between
parental and child cortisol levels. Specifically, we predict that parental and child cortisol
levels will be positively associated among healthy controls, but that this association will
be reduced among child cancer survivors. We also compare to healthy controls cancer
survivors who have and have not been treated with corticosteroids to determine whether
any cancer related effects can be attributed to the experience of cancer itself or to
potential steroid interference with HPA development.
METHODS
Participants
Participants (N=64 families, 85 children, children mean age=11 years, SD=4)
included two distinct groups: 32 families with children who were pediatric cancer
survivors (CS; child mean age in cancer survivor group=12 years, SD=4), and 32 families
with children who were healthy controls (HC; child mean age in healthy control
group=10 years, SD=3). Each child was assessed along with a primary caregiver (n=3, 2
sisters, 1 grandmother) or parent (n=61, 58 mothers, 3 fathers). Eligibility criteria for
children in both groups included: (a) age between 5 and 18 years, and (b) ability to follow
instructions in English. As this study involved additional components not reported here,
individuals were excluded from the study at the discretion of the investigator if they
could not adequately complete the tasks (e.g., child with visual impairment) or if they had
a diagnosis that interferes with cognitive or functional abilities (e.g. Learning Disorder,
IQ<70). Child cancer survivors also needed to have had a cancer diagnosis and be at least
one-year post treatment at the time of testing. Healthy control individuals were excluded
if they had been diagnosed with a chronic illness.
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Recruitment. A trained research assistant recruited potential cancer survivor
participant families during the child’s routine clinic visit at pediatric cancer follow-up
clinics within a children’s hospital. If the family indicated interest, they were either
immediately scheduled or contacted within a week to set up a time to return for the study.
HC families were recruited via online advertisements on Craigslist that included a brief
description of the study, compensation, and contact information.
Procedure
Study procedures were conducted with approval from the University of New
Mexico’s Institutional Review Board. The procedure is outlined in detail in Figure 1.
Here we report findings on only one (child cortisol) of several outcome measures, which
include: measures of child day-to-day impairment, executive functioning, and
intelligence were also collected. Once the family dyad arrived for the study visit,
consent/assent was obtained and hair samples collected. Next, the parent (or caregiver)
and child were separated for additional study procedures. The child completed a number
of measures for intelligence, executive functioning and functional impairment not
included in the current analyses. The parent was asked to give a saliva sample, complete
an amended version of the Trier Social Stressor Task (TSST; Kirschbaum, Pirke, &
Hellhammer, 1993) and provide a second saliva sample after answering demographic
questions as well as questions related to socioeconomic status (Barratt, 2012). The parent
then completed other measures not included in the current analyses. Upon completion of
the study measures, both parent and child received a gift card as compensation.
Measures
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Cortisol Measures. Within this study we examined cortisol collected
from both hair and saliva. Salivary and hair cortisol measurements are two conceptually
different measures of the same hormone. Salivary cortisol measurements assess
circulating cortisol levels at the time of sample collection and are used as measures of
stress regulation, allowing us to gauge participant stress response related to the TSST.
The hair measure allows one to assess the individual’s average exposure to perceived
stressful situations over approximately the past three months (Gow et al., 2010; Wennig,
2000).
For data analysis, we utilized the parent’s hair and both saliva samples, giving us
three different measures of parental cortisol, a baseline and a post-stress salivary cortisol
measure, as well as a measure of cumulative stress from hair. In addition, we calculated
a measure of normalized evoked cortisol, which evaluates the relative rise in cortisol
from baseline to post-stress. This normalized evoked cortisol measure was calculated by
the following formula: (CORTPOST-STRESS – CORTBASELINE)/ CORTBASELINE X100 =
CORTNORM_EVOKED, and assesses the relative change in cortisol from baseline to poststress (Tang, Reeb-Sutherland, Romeo, & McEwen, 2012). Individual differences in
HPA function can manifest as either variation in baseline cortisol, or variation in the
magnitude of response to a stressor, so we attempted to assess both measures in the
parent.
Hair cortisol. Parent and child cortisol levels were measured in hair samples.
This measurement of hair cortisol is a non-invasive technique, useful in assessing longterm cortisol production (Russell, Koren, Rieder, & Van Uum, 2012; Staufenbiel,
Penninx, Spijker, Elzinga, & van Rossum, 2012). It is insensitive to fluctuations in

!

7!

!
cortisol concentration due to short-term psychosocial stress or diurnal rhythm. Hair
cortisol (CORTHAIR) analysis captures the average cortisol secreted over a few months
(the assessment time period varies based upon hair length, the target is 3 months = 3 cm).
As hair dye may change the concentration of cortisol in the hair (Sauvé, Koren, Walsh,
Tokmakejian, & Van Uum, 2007), we statistically controlled for whether the parent’s hair
was dyed.
Approximately 150 strands of hair were taken from the vertex posterior of the
head (if the participant’s hair was too short for this collection method, small samples
were collected from multiple places on the head) from both parent and child. Hair was cut
with sanitized scissors as close to the scalp as possible. Cortisol was assayed in the
Hominoid Reproductive Ecology Laboratory at the University of New Mexico. The hair
samples were first ground to a fine powder using a Retsch ball mill, and then methanol
was used to extract cortisol from the samples. We added 2 ml of methanol to the ground
hair and incubated the sample overnight at 52°C in a water bath. The sample was
centrifuged for 15-20 minutes, and the supernatant was dispensed into a new test tube and
centrifuged for a second time for 15-20 minutes. Then, 1.5 ml of the supernatant was
pipetted into a clean glass tube and dried under nitrogen gas for 20-30 minutes. Lastly,
200ul of the assay diluent from Salimetrics was added to the dry sample and then this
mixture was vortexed to re-suspend the cortisol. Once the cortisol was extracted, cortisol
concentration was assessed in duplicate using Salimetrics ELISA cortisol assays (Gow,
Thomson, Rieder, Van Uum, & Koren, 2010; Sauvé et al., 2007; Yamada et al., 2007).
Two parents and seven children refused or did not have long enough hair for collection,
leaving 62 parent and 78 children who consented for us to obtain hair samples. The inter-
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assay CVs for cortisol controls (across both hair and saliva assays) were 1.71% and
6.53% for high and low controls, respectively, while the intra-assay CV for hair samples
was 7.14%.
Salivary cortisol. Salivary cortisol was collected in conjunction with an amended
version of the TSST. The TSST is a well-validated laboratory stressor requiring
participants to encounter psychosocial stress induced by a public speaking task. In the
classic TSST, participants are asked to give a 5-minute job talk after preparing for 10
minutes, and are then immediately given a mental arithmetic task (Kirschbaum et al.,
1993). In the present study, only the speech portion, rather than the speech and arithmetic
portions, of the TSST was utilized as previous research has shown that public speaking
elicits a greater overall physiological response than mental arithmetic (Al'Absi et al.,
1997). During the amended version of the TSST, participants were given 5 minutes to
prepare a 5-minute speech about their qualifications and reasons why they should be
hired for their dream job. If they could not speak for the whole 5 minutes, they were
prompted by questions from the researcher. Two saliva samples were collected in
conjunction with the TSST: the first immediately before the start of the TSST
(CORTBASELINE), and the second 5 minutes after the completion of the stressor
(CORTPOST-STRESS). The delay between baseline and post-stress sample collection was
approximately 10 minutes. This duration was chosen to ensure that the rising phase of
the stress response was captured for all participants, as the cortisol response to a stressor
peaks 10-30 minutes after the end of a stressor (Del Giudice, Ellis, & Shirtcliff, 2011).
Saliva was stored at -25 degrees Celsius until analysis, then vortexed and centrifuged to
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separate mucins. Salimetrics cortisol ELISAs were used to process samples in duplicate.
The intra-assay CV for duplicate aliquots of saliva samples was 6.30%.
The majority of samples were collected in the afternoon (mean time= 2:48 PM)
however; because the participant families determined scheduling, there was a wide range
of sample times (10:18 AM-5:50 PM). Since salivary cortisol levels are affected by time
of day (Gamble, Berry, Frank, & Young, 2014), we controlled for time of day in our
analyses.
Treatment severity. The researchers identified whether each cancer survivor
received cranial radiation therapy (CRT), intrathecal methatrexate (IT MTX), systemic
chemotherapy (SC), neurosurgery, or corticosteroid treatment via examining medical
records. Typically indexes of treatment severity exclude corticosteroid treatment, but the
present study examines HPA functioning, which may be affected by large doses of
corticosteroids (Gordijn et al., 2012; Kuperman et al., 2001; Mendoza-Cruz, Wargon,
Adams, Tran, & Verge, 2013)(for information regarding timing and dosage see Table 1).
Scores of 0 or 1 (0 if not given treatment, 1 if given treatment) were assigned for CRT, IT
MTX, SC, neurosurgery, and corticosteroid treatment. Treatment severity was derived
by summing these categorical treatment scores based on the procedure developed by
Vannatta, Gerhardt, Wells, and Noll (2007). Thus each cancer survivor was given a
treatment severity score ranging from 0-5.
Statistical Analyses
Data was first checked for normality and log-transformed when necessary. Only
cortisol measures required log transformation. Next, descriptive statistics were evaluated
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to assess for the presence of systematic differences between groups on demographic
variables such as child age, ethnicity, and sex.
As 13 of the 32 participant families in the HC group included siblings, the data
could not be handled as truly independent from one another, and thus multilevel
modeling was utilized, with parent ID as the level 1 factor and child ID as the level 2
factor. Before testing the hypotheses, it was first determined which variables needed to
be considered as covariates by performing backwards multilevel modeling entering all
possible covariates that were not directly associated with a predictor variable of interest.
These included child age, sex, and ethnicity; socioeconomic status; parent age, sex, and
ethnicity; time of saliva collection; and whether parent hair was colored. Due to issues of
statistical power, only the main effects of potential control variables were examined as
potential variables to be added to the model. Based upon the results of this analysis, child
age, child sex and parent ethnicity were included as control variables. The continuous
variables used in the models testing the hypotheses, parent cortisol measures and child
age, were centered before running the analyses. For all multilevel models, if the model
did not converge due to boundary constraints, the random intercept was removed,
allowing for convergence (Singer & Willett, 2003). Additionally, if a significant twoway interaction was found, follow-up simple effects analyses were run to determine the
differences between groups. For a follow-up analysis of the corticosteroid exposed CS
group, correlation of the unresidualized variables was used to identify the strength of
relation between parent and child.
To test the prediction that parental cortisol levels correlates with child cortisol
levels, several sets of multilevel models were run, one for each measure of parent
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cortisol. Three models were run for each parent cortisol measure. In the first model, the
predictor variables included child age, sex, parent ethnicity, group (cancer survivor or
control), the parent cortisol measure of interest, and the interaction term between group
and the parent cortisol measure of interest. The second and third models were run to
determine the extent to which treatment severity and corticosteroid exposure might
account for the effects related to the cancer experience. For the second model treatment
severity and the interaction between treatment severity and parent cortisol were added as
additional terms to the model. In the third and final model, instead of treatment severity,
child corticosteroid exposure and the interaction between corticosteroid exposure and the
parent cortisol measure were added as additional terms to the model.
Secondary Analyses. In order to comprehensively explore possible relationships
between predictor and control variables as well as how they may interact to predict child
HPA functioning, four backwards multilevel model analyses were performed, one for
each parent cortisol measure. In these analyses all interaction terms between the
predictor and control variables were entered. As these analyses capitalize on chance,
particular attention was paid to simple and interaction effects that significantly predicted
child cortisol concentrations within more than one analysis.
RESULTS
Participant Demographic Information
Intelligence, child age, child sex, parent ethnicity and socioeconomic status were
examined to identify any systematic demographic differences between the healthy control
and cancer survivor groups (Table 2). Children in the cancer survivor group were
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significantly older than healthy controls, averaging 12 versus 10 years of age (t(83)=2.598, p=.011). There were no other significant differences between groups.
Correlations of parent cortisol measures
Correlation was used to determine the relationship of how the four different
measures of parent cortisol were related. Parent CORTBASELINE and CORTPOST-STRESS
measures were significantly correlated (Rs=.714, p=.000, N=64; Table 3) as were parent
CORTBASELINE and CORTNORM_EVOKED measures (Rs=-.585, p=.000, N=64; Table 3). No
other significant correlations were found.
Interaction between parent cortisol and child experience of cancer
No main effect of cancer experience on child hair cortisol was found
(F(1,55.73)=.14, p=.710). However, there were main effects of parent CORTBASELINE
(F(1, 48.26)= 4.08, p=.049) and CORTPOST-STRESS (F(1,49.01) =8.29, p=.006) on child
CORTHAIR. Specifically, as either measure of parent cortisol increased, child CORTHAIR
also increased. When examining the relationship between cancer survivor group and
parental CORTBASELINE there was a significant 2-way interaction (F(1, 46.23)=4.53,
p=.039; Figure 2AB; Table 4) such that in the healthy control group parent cortisol was a
significant positive predictor of child cortisol (F(1,24.24)=4.25, p=.050), while in the
cancer survivor group no correlation was observed between parent CORTBASELINE and
child CORTHAIR (F(1,24)=.149, p=.700). We found similar results were observed when
examining the 2-way interaction between parental CORTPOST-STRESS and child CORTHAIR
(F(1,47.12)=8.99, p=.004; Figure 2AB; Table 5); child CORTHAIR was positively
predicted by parent CORTPOST-STRESS in the HC group (F(1,25.93)=9.12, p=.006), but not
in the CS group (F(1,24)=.154, p=.699). No significant effects were found between either
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parent CORTNORM_EVOKED (interaction: F(1,56.81)=.026, p=.873; main effect:
F(1,59.02)=.001, p=.970) or parent CORTHAIR (interaction F(1,68)=1.69, p=.198, main
effect F(1,68)=1.13, p=.292) and child CORTHAIR.
Interaction of Parent Cortisol Levels and Child Corticosteroid Exposure on Child
Cortisol Levels
To determine what aspect of the cancer experience may be responsible for the the
change in relationship between parent and child cortisol, treatment severity and child
corticosteroid exposure were examined. No main effect of treatment severity was found
(F(1,49.11)=.938, p=.338). Additionally, no significant interaction effects were observed
between treatment severity and parent cortisol levels on child CORTHAIR (CORTBASELINE
F(1,61.98)=.242, p=.624; CORTPOST_STRESS F(1, 62.35)=.136, p=.714; CORTNORM_EVOKED
F(1,56.81)=.026, p=.873; CORTHAIR F(1, 54.16)=.881, p=.352).
No significant main effect of corticosteroid exposure was found
(F(1,55.81)=.078, p=.782). However there was a significant 2-way interaction between
both parent CORTBASELINE and CORTPOST_STRESS levels and child corticosteroid exposure
on child CORTHAIR, (CORTBASELIINE: F(1,61.02)=4.76,p=.033, Table 6; CORTPOST_STRESS
: F(1,68)=5.79, p=.019, Table 7) was observed. Specifically, the cortisol levels of cancer
survivors exposed to corticosteroids were negatively related to their parents’ cortisol
(CORTBASELINE : F(1,5)=1.873, p=.229, Rs=-.592, n=11, p=.055; CORTPOST_STRESS :
F(1,5)=2.97, p=.145, Rs=-.633, n=11, p=.036; Figure 2CD), while the cortisol levels of
cancer survivors not given corticosteroids, similar to healthy controls, were positively
correlated to their parents’ (Figure 2CD; CORTBASELINE: F(1,40.46) =6.114, p=.018;
CORTPOST-STRESS: F(1,41.66)=11.81, p=.001). We found no statistical difference
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correlation between parent and child cortisol in the healthy control group versus the
cancer survivor group not exposed to corticosteroids: parent CORTBASELINE
(F(1,39.54)=1.23, p=.274) and CORTPOST-STRESS (F(1,40.546)=3.27, p=.078) measures.
Interaction of Cancer Experience, Parental Ethnicity & Child Sex on Child Cortisol
Levels
Through exploratory analyses, a 3-way interaction among cancer experience,
parent ethnicity, and child sex on child CORTHAIR levels (F(6,48.14)=2.998, p=.014)).
Specifically, females in the cancer survivor group had higher levels of cortisol compared
to females in the healthy control group regardless of parent ethnicity, while male cancer
survivors had cortisol levels lower than healthy controls if the parent was Hispanic or
Non-Hispanic or White. Additionally, a significant 2-way interaction was found between
child sex and parent ethnicity (F(5,38.55)=5.31, p=.001), such that female cortisol levels
were generally the same regardless of parent ethnicity, while male cortisol levels were
similar when parents were White or Hispanic but higher when parents were another
ethnicity.
Discussion
The cancer experience was not found to affect the average cortisol levels of
children but did modify the association between parent and child cortisol levels.
Specifically, while parent and child cortisol levels were positively associated among
healthy control families, this effect was not observed in cancer survivor families. Followup analyses revealed that the difference in this relationship was unrelated to the cancer
experience itself, but confined to the subgroup of children who were treated with high
levels of corticosteroids.
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The finding that the experience of cancer alone did not significantly change child
HPA function was surprising because other types of chronic stress, including
maltreatment (Fisher et al., 2011) and chronic diseases such as HIV and wasting
disorders (Zeitler et al., 1999), lead to HPA axis dysfunction. Thus, while pediatric
cancer may affect child psychological outcomes (Ellenberg et al., 2009; Pelcovitz et al.,
1998; Zeltzer et al., 2008), in the present study there is no evidence that the cancer
experience alone affects child cortisol or the relationship between parent and child
cortisol. More surprising, we did not find a main effect of high corticosteroid exposure.
Other research examining the effects of high doses of corticosteroids has found that this
exposure altered child HPA axis function (Gibbison, Angelini, & Lightman, 2013;
Moisiadis & Matthews, 2014). While we did not find a difference in cortisol levels
between pediatric cancer survivors and healthy controls, or related to cancer-related
corticosteroid exposure, there may still be differences in these groups’ HPA regulation
(Gordijn et al., 2012) that were not reflected in long-term average cortisol levels
expressed in children’s hair. It is possible that these individuals have a bunted cortisol
response to stress, which may be undetectable within hair. While the main effects of
cancer experience and corticosteroid exposure did not show any changes in child cortisol
within the current study we also examined HPA function by testing whether a
consistently observed correlation was present within the sample. Specifically we
examined if the consistently observed relationship of parent cortisol positively predicting
child cortisol was still found after children experienced the chronic stress of cancer and
the HPA axis perturbation of corticosteroid exposure. Indeed, the discordance between
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parent and child cortisol in the corticosteroid treatment group suggests altered HPA axis
regulation.
Parent and child cortisol levels have been shown to positively relate to one
another from infancy (Stenius et al., 2008) until at least adolescence (Papp, Pendry, &
Adam, 2009). This long lasting relationship between parent and child cortisol levels
suggests that parental stress levels help to shape the maternal environment to which the
child is exposed (Tang, Reeb-Sutherland, Romeo, & McEwen, 2014). Moreover, the
maternal environment, along with other non-maternal factors, influence child HPA axis
function and cortisol levels. Our results support this hypothesis, as for both healthy
control children and children who experienced cancer but were not given steroids, we
found a positive relationship between parent and child cortisol.
There are a number of possibly interrelated mechanisms as to how parent stress
may affect child HPA axis function. These include: (a) parental stress leading to changes
in parental behavior and then to child stress (Marceau, et al., 2013); (b) parental stress
leading to epigenetic changes in the child that affect aspects of glucocorticoid function
(Yehuda, et al., 2014); and (c) child HPA function being influenced directly by exposure
to maternal stress hormones in utero (Reynolds, 2013), and during breastfeeding
(Angelucci, Pataccchioli, Chierichetti, and Laureti, 1983), leading to similar
responsiveness. Alternatively, child behavior may affect parental stress (Seltzer, et al.,
2010), or parents and children may experience the same stressors due to the shared
environment (Hunter, Minnis, & Wilson, 2011). Finally, shared genes (Kirschbaum,
Wust, Faig, & Hellhammer, 1992) may affect parent and child HPA axis function. The
current study was not designed to discriminate these alternative hypotheses. However,

!

17!

!
prior research indicates that when children experience stress, the relationship between
parent and child cortisol levels breaks down (Clearfield et al., 2014; Hibel et al., 2014), a
finding that we re-examined in our study of pediatric cancer survivors.
We found that children exposed to high doses of corticosteroids had an inverse
relationship between parent and child cortisol, such that if parents had low salivary
baseline or post-stress cortisol levels, their children were more likely to have high hair
cortisol. Without this exposure to a high dosage of corticosteroids, pediatric cancer
survivors had cortisol levels positively related to their parents, statistically
indistinguishable from the relationship observed among healthy control children. These
findings imply that the cancer experience itself did little to change the long-term parent
child cortisol relationship, and that high doses of exogenous corticosteroids are
responsible for the changes in this relationship. The negative association found in the
corticosteroid exposure group could be explained by interference in HPA axis regulation
via negative feedback, a process that may be especially sensitive to perturbation in
developing children. Exposure to high levels of endogenous or exogenous corticosteroids
can alter HPA negative feedback loops by down regulation of glucocorticoid receptors in
the hypothalamus (Barden, 2004) or alternatively by increased sensitivity or upregulation
of these glucocorticoid receptors (Yehuda, 2003). These changes in negative feedback
may result in increased susceptibility to distress and PTSD (Lesko, 1990; Pelocovitz et
al., 1998; Zeltzer et al., 2008).
Our results imply that high dose corticosteroid exposure may have long-lasting
impacts on child HPA axis function (Gibbison, Angelini, & Lightman, 2013; Moisiadis &
Matthews, 2014). It is unknown whether this attenuation between parent and child HPA
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function is damaging or beneficial to child functional outcomes. Yet, the limited
functional outcome data for this study does indicate that the attenuation does not
adversely impact child IQ. Prospective studies, may be able to answer this question by
specifically assessing functional outcomes in children who show an attenuated
relationship between their parents and their own cortisol levels. However since we are
unsure what the long lasting impact of these steroid exposure might be, it is important to
use these corticosteroid treatments with caution.
Limitations
This current presentation of the cancer experience and its effect upon child
developmental outcomes is narrowly focused, as there are a number of other contextual
factors, including treatment complications and child history before cancer diagnosis, that
are not included but which may affect child HPA functioning. The results of this present
study will need to be considered with these contextual factors in mind. Two of the
limitations of this study are: 1) that there was a highly diverse group of participants (i.e.,
a broad range of cancer diagnoses), thus the experience of cancer was not uniform (e.g.
treatment that varied in length and intensity), and 2) the study is limited by its cross
sectional nature, thus shedding little light on causal factors. An additional limitation
related to the sample size of this study is that siblings were included for more healthy
controls than cancer survivor families. This may introduce discrepancies between the
groups along with possible unequal variance. Additionally, there were unequal group
sizes when examining factors not selected for during recruitment such as parental
ethnicity and corticosteroid exposure. Unequal group sizes may decrease the robustness
of the results. Conceptually there is ambiguity in interpreting the meaning of hair cortisol
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levels, as this integrated measure does not allow one to distinguish individuals who have
high baseline cortisol from those who have low baseline cortisol but experience frequent,
strong stress responses. It was surprising that hair cortisol levels were not correlated with
other parental measures of cortisol, as it has been previously shown that circulating and
hair cortisol levels are modestly correlated (Xie et al., 2011). One explanation for this
discrepancy may be that some parents used hair products that could have interfered with
the assay. Additionally, most of the parents were mothers and we did not account for
whether these women were taking oral contraceptives, which may affect HPA
functioning (Kirschbaum, Kudielka, Gaab, Schommer, & Hellhammer, 1999; Roche,
King, Cohoon, & Lovallo, 2013). Furthermore, unlike rodent studies (Tang et al., 2012),
normalized evoked cortisol was not found to predict child cortisol; this may be due to
variability in the baseline sample due to stress related to coming to a research laboratory.
Some participants may have found coming to the University and being part of the study a
stressor and therefore had high cortisol levels at the beginning of the study. Also,
differences between groups’ cortisol may have been present but undetectable. This could
be due to variations in collection protocol due to multiple research assistants collecting
data as well as the modest sample size for the corticosteroid exposed group. Lastly, when
generalizing these results to other populations, we use caution, as this sample may have a
lower SES than the typical American sample as this sample was taken from one of the
lowest income states in the country and a minority-majority state.
Conclusions
The relationship between parent and child HPA function is significantly changed
when children are given high doses of corticosteroids during cancer treatment. However,
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children who were exposed to corticosteroids or who experienced the chronic stress of
cancer had similar cortisol levels compared to healthy controls. Furthermore, the
relationship between parent and child HPA function did not change as a result of the
cancer treatment, but did change as a result of corticosteroid exposure. If the child was
exposed to corticosteroids, this direct perturbation to the child’s HPA axis attenuated the
parent child cortisol relationship. This research may provide evidence that corticosteroids
given to children as part of cancer treatment perturb the HPA axis, which is already
vulnerable as the child experiences the multitude of stressors related to the cancer
experience. These findings are significant because most children who are diagnosed with
cancer survive (Institute of Medicine, 2003) but experience devastating late effects. At
least some of these effects, particularly those related to psychological well-being, are
known to interact with HPA function. When the effects of pediatric cancer treatment
severity are examined, child corticosteroid exposure is frequently. Thus, some of the
effects currently attributed to cancer may actually be related to corticosteroid exposure.
More may aid in the development of more effective interventions for these children.
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Figure 1

Experimental Timeline. Upon arrival to the laboratory, parent and child are first
consented and then hair samples are taken from both individuals. Next, parent and child
are separated. Parent is administered an amended version of the Trier Social Stressor
Task (TSST) during which time two saliva samples are collected. After the TSST, parents
are asked to respond to the Brief Impairment scale (BIS) rating their child’s day-to-day
impairment. Finally they are asked to fill out four subscales of the Family Environment
Scale. Children are first administered the Reynolds Intellectual Screening Task (RIST)
and are then their executive functioning is evaluated via the NIH Examiner. Lastly they
are asked to respond to the child version of the Brief Impairment scale rating their own
day-to-day impairment.
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Figure 2

Interaction between parent saliva and child hair cortisol levels by child experience
of cancer and interaction between child corticosteroid use and parent salivary cortisol on
child hair cortisol. All data displayed above are residuals. For both parent baseline (A)
and post-stress cortisol (B) for healthy controls (black line; n=49) there is a positive
association between parent and child cortisol. However, for cancer survivors (purple line;
n=29), this relationship is less positive. When examining how child corticosteroid use
due to cancer treatment predicts the relationship between parent and child cortisol (C and
D), those children given corticosteroids as part of cancer treatment (red line; n=11) have
a negative association between parent baseline and post-stress and child hair cortisol
levels, children who are cancer survivors unexposed to corticosteroids (blue line; n=18)
have a relationship with parent cortisol similar to healthy controls (black line; n=49).
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Table 1: Information regarding corticosteroid treatment for children given steroids as part
of cancer treatment.
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Table 2: Child Demographic Information
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Table 3. Parent cortisol measures correlations
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Table 4
Type%III%Tests%of%Fixed%Effects%for%Parent%CORTBASELINE%X%Cancer%Experience%
Denominator%

Numerator%df%
Source%

df%

F%

Sig.%

Intercept%

1%

53.052%

666.156%

.000%

group%

1%

55.725%

.140%

.710%

Child%sex%

1%

53.788%

14.458%

.000*%

child%age%

1%

68.566%

2.867%

.095%

Parent%ethnicity%

2%

54.411%

2.193%

.121%

Parent%CORTBASELINE%

1%

48.256%

4.078%

.049*%

group%*%Parent%CORTBASELINE%

1%

46.231%

4.530%

.039*%

Estimates%of%Fixed%Effectsa%
Parameter%

Estimate%

Std.%

df%

t%

Sig.%

95%%Confidence%Interval%

Error%
%

%

%

%

%

%

Lower%

Upper%

Bound%

Bound%

Intercept%

1.476403%

.126668%

58.581%

11.656%

.000%

1.222904%

1.729903%

[group=control]%

5.032171%

.086047%

55.725%

5.374%

.710%

5.204564%

.140221%

0%

0%

.%

.%

.%

.%

.%

5.256667%

.067502%

53.788%

53.802%

.000%

5.392012%

5.121322%

0%

0%

.%

.%

.%

.%

.%

.016879%

.009969%

68.566%

1.693%

.095%

5.003011%

.036769%

[parent%ethnicity%=.Hispanic]%

5.154961%

.120563%

52.334%

51.285%

.204%

5.396852%

.086929%

[parent%ethnicity%=White]%

5.272561%

.131520%

53.469%

52.072%

.043%

5.536302%

5.008820%

0%

0%

.%

.%

.%

.%

.%

Q.002143%

.060304%

59.869%

Q.036%

.972%

Q.122774%

.118488%

.184842%

.086849%

46.231%

2.128%

.039%

.010048%

.359636%

0%

.%

.%

.%

.%

.%

b

[group=cancer%survivor]%
[child%sex=female]%

b

[child%sex=male]%
child%age%

b

[parent%ethnicity%=Other]%
Parent%CORTBASELINE%
[group=control]%*%Parent%
CORTBASELINE%

b

[group=cancer%survivor]%*%

0%

Parent%CORTBASELINE%
a.%Dependent%Variable:%child%CORTHAIR.%
b.%This%parameter%is%set%to%zero%because%it%is%redundant.%
%

!

32!

!

Table 5
Type%III%Tests%of%Fixed%Effects%for%Parent%CORTPOSTQSTRESS%X%Cancer%Experience%
Denominator%
Source%

Numerator%df%

df%

F%

Sig.%

Intercept%

1%

51.033%

760.315%

.000%

Child%sex%

1%

56.678%

16.847%

.000*%

Child%age%

1%

68.839%

5.283%

.025*%

Parent%ethnicity%

2%

51.677%

2.419%

.099%

group%

1%

55.093%

.006%

.939%

Parent%CORTPOST_STRESS%

1%

49.007%

8.290%

.006*%

group%*%Parent%CORTPOST_STRESS%

1%

47.209%

8.994%

.004*%

Estimates%of%Fixed%Effectsa%
Parameter%

Estimate%

Std.%

df%

t%

Sig.%

95%%Confidence%Interval%

Error%
%

%

%

%

%

%

Lower%

Upper%

Bound%

Bound%

Intercept%

1.468463%

.119922%

57.213%

12.245%

.000%

1.228344%

1.708583%

[child%sex=female]%

5.272101%

.066293%

56.678%

54.105%

.000%

5.404867%

5.139335%

0%

0%

.%

.%

.%

.%

.%

.022522%

.009799%

68.839%

2.298%

.025%

.002973%

.042072%

[parent%ethnicity%=.Hispanic]%

5.141227%

.113351%

49.665%

51.246%

.219%

5.368936%

.086482%

[parent%ethnicity%=White]%

5.266426%

.123815%

50.936%

52.152%

.036%

5.515003%

5.017849%

0%

0%

.%

.%

.%

.%

.%

5.006286%

.081191%

55.093%

5.077%

.939%

5.168991%

.156419%

0%

0%

.%

.%

.%

.%

.%

Q.003605%

.052480%

59.710%

Q.069%

.945%

Q.108592%

.101381%

.239787%

.079957%

47.209%

2.999%

.004%

.078953%

.400621%

0%

.%

.%

.%

.%

.%

b

[child%sex=male]%
child%age%

b

[parent%ethnicity%=Other]%
[group=control]%

b

[group=cancer%survivor]%
Parent%CORTPOST_STRESS%
[group=control]%*%Parent%
CORTPOST_STRESS%
[group=cancer%survivor]%*%

b

0%

Parent%CORTPOST_STRESS%
a.%Dependent%Variable:%child%CORTHAIR.%

b.%This%parameter%is%set%to%zero%because%it%is%redundant.%
%

!

33!

!
Table 6
Type%III%Tests%of%Fixed%Effects%for%Parent%CORTBASELINE%X%Corticosteroid%Exposure%
Denominator%

Numerator%df%
Source%

df%

F%

Sig.%

Intercept%

1%

56.140%

378.193%

.000%

Child%sex%

1%

52.372%

17.739%

.000*%

Child%age%

1%

66.534%

2.816%

.098%

Parent%ethnicity%

2%

53.418%

2.248%

.116%

group%

1%

56.199%

.101%

.752%

Steroid%group%

1%

60.548%

.029%

.865%

Parent%CORTBASELINE%

1%

57.763%

.119%

.732%

group%*%Parent%CORTBASELINE%

1%

47.190%

1.440%

.236%

Steroid%group*%Parent%CORTBASELINE%

1%

61.021%

4.764%

.033*%

Estimates%of%Fixed%Effectsa%
Parameter%

Estimate%

Std.%

df%

t%

Sig.%

95%%Confidence%Interval%

Error%
%

%

%

%

%

%

Lower%

Upper%Bound%

Bound%
Intercept%
[child%sex=female]%

1.468656%

.151823%

58.312%

5.284906%

.067645%

52.372%

.000%

1.164784%

1.772528%

.000%

5.420623%

5.149188%

0%

0%

.%

.%

.%

.%

.%

.016831%

.010029%

66.534%

1.678%

.098%

5.003190%

.036852%

5.158586%

.118216%

51.409%

1.342%

.186%

5.395868%

.078696%

5.273843%

.130011%

52.639%

.040%

5.534654%

5.013032%

0%

0%

.%

.%

.%

.%

.%

5.030949%

.097503%

56.199%

5.317%

.752%

5.226255%

.164357%

0%

0%

.%

.%

.%

.%

.%

.021668%

.127107%

60.548%

.170%

.865%

5.232536%

.275871%

0%

0%

.%

.%

.%

.%

.%

5.227479%

.119126%

62.031%

.061%

5.465607%

.010649%

.110131%

.091769%

47.190%

1.200%

.236%

5.074465%

.294726%

0%

0%

.%

.%

.%

.%

.%

.297806%

.136436%

61.021%

2.183%

.033%

.024987%

.570625%

0%

.%

.%

.%

.%

.%

b

[child%sex=male]%
child%age%
[parent%ethnicity%=.Hispanic]%
[parent%ethnicity%=White]%

b

[parent%ethnicity%=Other]%
[group=control=0]%

b

[group=cancer%survivor=1]%
[Steroid%group=no%exposure=0]%

b

[Steroid%group=exposure=1]%
Parent%CORTBASELINE%
[group=0]%*%Parent%CORTBASELINE%
[group=1]%*%Parent%CORTBASELINE%
[ster_2grps=0]%*%Parent%CORTBASELINE%
[ster_2grps=1]%*%Parent%CORTBASELINE%

b

b

0%

9.673%
5
4.212%

5
2.106%

5
1.910%

a.%Dependent%Variable:%Child%CORTHAIR.%b.%This%parameter%is%set%to%zero%because%it%is%redundant%
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Table 7
Type%III%Tests%of%Fixed%Effects%for%Parent%CORTPOSTQSTRESS%X%Corticosteroid%Exposure%
Denominator%

Numerator%df%
Source%

df%

F%

Sig.%

Intercept%

1%

68%

495.297%

.000%

Child%sex%

1%

68%

17.230%

.000*%

child%age%

1%

68%

7.295%

.009*%

parent_ethnic_3groups%

2%

68%

3.650%

.031*%

group%

1%

68%

.195%

.660%

Steroid%group%

1%

68%

.092%

.762%

Parent%CORTPOST_STRESS%

1%

68%

.102%

.750%

group%*%Parent%CORTPOST_STRESS%

1%

68%

4.553%

.036*%

Steroid%group%*%Parent%CORTPOST_STRESS%

1%

68%

5.787%

.019*%

a

Estimates%of%Fixed%Effects %
Parameter%

Estimate%

Std.%

df%

t%

Sig.%

95%%Confidence%Interval%

Error%
%

%

%

%

%

%

Lower%

Upper%Bound%

Bound%
Intercept%

1.482125%

.142390%

57.869%

10.409%

.000%

1.197088%

1.767163%

[child%sex=female]%

5.301845%

.065751%

56.000%

54.591%

.000%

5.433559%

5.170130%

0%

0%

.%

.%

.%

.%

.%

.022993%

.009806%

66.860%

2.345%

.022%

.003419%

.042567%

[parent%ethnicity%=.Hispanic]%

5.144775%

.110045%

49.548%

51.316%

.194%

5.365856%

.076306%

[parent%ethnicity%=White]%

5.265049%

.121274%

50.776%

52.186%

.033%

5.508543%

5.021555%

0%

0%

.%

.%

.%

.%

.%

.014255%

.092057%

56.760%

.155%

.877%

5.170104%

.198613%

0%

0%

.%

.%

.%

.%

.%

5.018636%

.119805%

61.764%

5.156%

.877%

5.258142%

.220869%

0%

0%

.%

.%

.%

.%

.%

Q.200416%

.097029%

68%

Q2.066%

.043%

Q.394034%

Q.006799%

.164931%

.077292%

68%

2.134%

.036%

.010698%

.319164%

0%

0%

.%

.%

.%

.%

.%

.271489%

.112859%

68%

2.406%

.019%

.046282%

.496696%

0%

.%

.%

.%

.%

.%

b

[child%sex=male]%
%child%age%

b

[parent%ethnicity%=Other]%
[group=control=0]%

b

[group=cancer%survivor=1]%
[steroid%group=%no%exposure=0]%

b

[steroid%group=exposure=1]%
Parent%CORTPOST_STRESS%
[group=0]%*%Parent%CORTPOST_STRESS%
[group=1]%*%Parent%CORTPOST_STRESS%
[ster_2grps=0]%*%Parent%
CORTPOST_STRESS%
[ster_2grps=1]%*%Parent%

b

b

0%

CORTPOST_STRESS%

a.%Dependent%Variable:%Child%CORTHAIR,%b.%This%parameter%is%set%to%zero%because%it%is%redundant.%
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